Cardiac Enzymes And Cardiac Peptides As Biomarkers Of Cardiovascular Risk Associated With Obesity
Obesity
prevalence is increasing worldwide among children, adolescents and adults.
Obesity is classified as a chronic disease and is known to contribute to an
increased risk of cardiovascular diseases. Cardiovascular diseases are disorders affecting the heart and blood
vessels. They encompasses disorders such as coronary heart disease, heart
failure, cerebrovascular disease, stroke, rheumatic heart disease. They
constitute leading causes of death. Childhood obesity is associated with cardiovascular
diseases, accelerated vascular aging and related risk factors. Deteriorated
diastolic function, atrial conduction and heart rate responses were also
reported in obese children. The early prediction of cardiovascular disease risk,
therefore, gains importance for the prevention of this group of lethal
diseases. The aim of this chapter was to
summarize existing novel circulating biomarkers as well as new generation
biomarkers in addition to well-known and widely used traditional biomarkers
concerning cardiovascular problems. Reports related to the matter in pediatrics
field were scarce. The introduction of recent limited number of studies
performed on children and adolescents is quite important. The chapter was
focused particularly on cardiac enzymes and cardiac peptides. The aim was to
guide future studies in pediatric population on cardiac enzymes and peptides
commonly studied in adults.
Kitap Adı:
General Internal Medicine Vii
Atıf Sayısı :
